G(−30)A Polymorphism in the Pancreatic Promoter of the Glucokinase Gene Associated With Angiographic Coronary Artery Disease and Type 2 Diabetes Mellitus

Background—Type 2 diabetes mellitus (T2DM) increases the risk of coronary artery disease (CAD). A G(−30)A polymorphism in the β-cell–specific promoter of glucokinase (GK-30PM) has been implicated in reduced pancreatic β-cell function. Its impact on CAD has not been examined. Methods and Results—The glucokinase G(−30)A variant was determined in 2567 patients with angiographic CAD and in 731 individuals in whom CAD had been ruled out by angiography. In carriers of the A allele, the adjusted OR of CAD was 1.39 (95% CI, 1.15 to 1.70). Corresponding ORs were 1.27 (95% CI, 1.02 to 1.59) and 1.92 (95% CI, 1.26 to 2.93) in individuals without and with T2DM, respectively. The prevalence of the A allele increased in parallel with the Friesinger coronary score. Patients with T2DM were more frequent among carriers of ≥1 A allele (OR, 1.17; 95% CI, 1.00 to 1.28). This association was stronger if CAD patients only were considered. The A allele was associated with higher glucose (fasting, P =0.002; 2 hours after oral glucose, P =0.017) and glycohemoglobin (HbA1c; P =0.002). Furthermore, presence of 1 A allele was negatively related to β-cell function, estimated by β percent (P =0.012) and by the ratios of proinsulin to insulin (P =0.025) and proinsulin to C peptide (P =0.019). Conclusions—The A allele of the pancreatic promoter of glucokinase increases the risk of CAD in individuals with and without T2DM. Furthermore, at least in CAD, it is associated with an augmented prevalence of T2DM.

[1]  M. Permutt,et al.  A genetic marker at the glucokinase gene locus for Type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles , 1992, Diabetologia.

[2]  D. Pyke,et al.  Diabetes in identical twins , 1981, Diabetologia.

[3]  M. Permutt,et al.  Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning , 2004, Diabetologia.

[4]  J. Grippo,et al.  Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy , 2003, Science.

[5]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[6]  R. Hegele.  SNP judgments and freedom of association. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[7]  G I Bell,et al.  Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. , 2001, The New England journal of medicine.

[8]  W. März,et al.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. , 2001, Pharmacogenomics.

[9]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[10]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[11]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[12]  Glucokinase Gene Islet Promoter Region Variant (G→A) at Nucleotide −30 Is Not Associated With Reduced Insulin Secretion in Finns , 1998, Diabetes Care.

[13]  A. Koyanagi,et al.  Clinical Characteristics of Japanese Men With Glucokinase Gene β-cell Promoter Variant , 1997, Diabetes Care.

[14]  Å. Lernmark,et al.  The beta cell glucokinase promoter variant is an unlikely risk factor for diabetes mellitus , 1997, Diabetologia.

[15]  D. Porte,et al.  A Variation at Position −30 of the β-Cell Glucokinase Gene Promoter Is Associated With Reduced β-Cell Function in Middle-Aged Japanese-American Men , 1996, Diabetes.

[16]  S. Kahn,et al.  A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. , 1996, Diabetes.

[17]  R. E. Rowe,et al.  Linkage and association between insulin–dependent diabetes mellitus (IDDM) susceptibility and markers near the glucokinase gene on chromosome 7 , 1995, Nature Genetics.

[18]  M. Knip,et al.  Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group. , 1994, The Journal of clinical endocrinology and metabolism.

[19]  A. Kitabchi,et al.  Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome. , 1994, Metabolism: clinical and experimental.

[20]  Y. Yazaki,et al.  Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. , 1994, The Journal of clinical endocrinology and metabolism.

[21]  G. Bell,et al.  Mutations in the Glucokinase Gene are not a Major Cause of Late‐onset Type 2 (Non‐insulin‐dependent) Diabetes Mellitus in Japanese subjects , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[22]  J. Beckmann,et al.  Linkage Analysis and Molecular Scanning of Glucokinase Gene in NIDDM Families , 1993, Diabetes.

[23]  M. Permutt,et al.  Polymorphic Microsatellite Repeat Markers at the Glucokinase Gene Locus Are Positively Associated With NIDDM in Japanese , 1993, Diabetes.

[24]  M. Permutt,et al.  Glucokinase Gene is Genetic Marker for NIDDM in American Blacks , 1992, Diabetes.

[25]  R. Bergman,et al.  Relationship of insulin clearance and secretion to insulin sensitivity in non‐diabetic Mexican Americans , 1992, European journal of clinical investigation.

[26]  P. Savage,et al.  C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. , 1979, The Journal of clinical endocrinology and metabolism.

[27]  R. Frye,et al.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. , 1975, Circulation.

[28]  G. Friesinger,et al.  Prognostic significance of coronary arteriography. , 1970, Transactions of the Association of American Physicians.